Загрузка...
The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs
Historically, advocates of randomized drug treatment trials in oncology contributed to the changing paradigm for testing cancer treatments in the U.S., which led to global efforts to generate evidence of promise in preclinical model systems and translate those findings into improved patient outcomes...
Сохранить в:
| Опубликовано в: : | Oncologist |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AlphaMed Press
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5599203/ https://ncbi.nlm.nih.gov/pubmed/28620092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0153 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|